SCHEMBL7785595

SCHEMBL7785595

N=C(N)NN(c1cccc(C(CC(=O)O)NC(=O)c2cccs2)c1)S(=O)(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 2/20 0.42
MMP3 P08254 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
MMP13 P45452 1/20 0.42
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HTT P42858 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 1/20 0.38
ALOX12 P18054 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CTSA P10619 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7194899 0.89 ITGB3 (0.44) MAPTMEN1KMT2AALDH1A1CYP3A4
SCHEMBL7781206 0.85 ITGB3 (0.42) MMP12MMP3MMP9MMP8MMP13
SCHEMBL7781180 0.85 EEF2K (0.46) CTSA
SCHEMBL7790178 0.85 CTSA (0.41) MMP12MAPTMEN1KMT2ANPC1
SCHEMBL7789969 0.85 CYP26A1 (0.42) MAPTHTTALDH1A1SMN1; SMN2GAA
SCHEMBL7785625 0.85 EEF2K (0.41) MAPTMEN1KMT2AALDH1A1TSHR
SCHEMBL7788749 0.84 ITGB3 (0.44) MAPTMEN1KMT2ACYP3A4CYP2C9
SCHEMBL7790073 0.84 CYP26A1 (0.46) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7786241 0.84 CTSA (0.46) MEN1KMT2AALDH1A1GAACTSA
SCHEMBL7786214 0.83 S1PR3 (0.41) MEN1KMT2AALDH1A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147079-A2 BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS Bayer Aktiengesellschaft (DE) 2001-10-24 EP disclosed
WO-2000041469-A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed